SHORT COMMUNICATIONS
4oo BBA 53121
Apparent non-specific effect of bile salts on the terminal cholesterol biosynthesis by rat liver Cholesterol
is biosynthesized
is formed is further
converted
by rat-liver
into bile salts.
reactions of
enzymes I. Much of the cholesterol Thus, bile salts may be considered
that an
end-product of hepatic cholesterol biosynthesis. Recently, FIMOGNARI AND RODWELL (refs. 2, 3) demonstrated that certain bile salts inhibit the conversion of P-hydroxy,%methylglutaryl-CoA
into mevalonic
acid. These workers
suggested
that bile salts
thus serve as end-product inhibitors of this early reaction of cholesterol biosynthesis. In steroid-secreting tissues, steroid hormones are the end products of cholesterol metabolism. End-product steroids inhibit the oxidative demethylation of lanosterol which is one of the terminal reactions of cholesterol biosynthesis that are catalyzed by microsomal enzymes 4. Thus, the effect of bile salts on the lanosterol demethylation reactions of cholesterol biosynthesis was investigated to determine whether or not bile salts inhibit these terminal reactions of cholesterol biosynthesis by liver. Crude homogenate of rat liver was prepared by centrifuging Bucher homogenates of rat liver at IOOOOxg for 20 min (ref. 5). Microsomes were prepared by centrifugation of crude homogenate for I h at 105000~g; the pellet was suspended in 0.1 M potassium phosphate buffer (pH 7.4, 30 mM nicotinamide). The volume of microsomal suspension was adjusted to 25% of the volume of crude homogenate. The rate of oxidative demethylation of [14C]lanosterol (225 to 400 disint./min per mpmole) into [W]cholesterol and other C,,-sterols was determined by the collection
I OO
IO
20
30
First incubation (min) Fig. I. Time course of inactivation by bile salts. Microsomes (160-320 mg protein) and 12 ,umoles NAD were first incubated at 37O alone (O---C?), with 2.5 mM taurodeoxycholate (A---&, or with 0.3 mM glycolithocholate (m---m). After incubation times of o, 5, IO, 15, 20, and 30 min. r-ml samples (20-40 mg protein) of the first incubation mixture were added to 40 m/Lmoles of [‘%]lanosterol, and the mixtures were incubated a second time at 37’ for 5 min. The final volume for the second incubation was 1.2 ml. Fig. 2. Effect of glycolithocholate on the rate of demethylation. Microsomes (160-320 mg protein) and 12 pmoles NAD were first incubated for 12 min at 37’ either alone (o---c) or with 0.5 (A---A) or 0.3 (m--m) mM glycolithocholate. Microsomes (20-40 mg protein) from the first incubation were added to 16, 24, 40, and IOO m,umoles of [‘%Jlanosterol substrate; a second incubation was continued at 37’ for IO min. The final volume for the second incubation was I.5 ml.
Biochim.
Biophys.
Acta,
137 (1967) 400-402
SHORT
401
COMMUNICATIONS
of r4C0, as described previously5. [14C]Lanosterol was prepared from [z-14C]mevalonate5. When conditions of initial reaction rates were investigated (Figs. I and z), microsomes were incubated less than IO min (ref. 5) ; other samples were incubated for 15 or 30 min as described. Solutions of bile salts in 0.1 M potassium phosphate buffer (final pH 7.4) were added to the incubation flasks. Turbid samples were discarded. Incubation of crude homogenate with 1.3 mM deoxycholate, taurodeoxycholate, taurochenodeoxycholate, glycodeoxycholate, glycolithocholate, or glycochenodeoxycholate yielded inhibition of 25% or more (Table I). Many of the other compounds listed in Table I and taurine, biliverdin, and bilirubin were either less active or completely inactive at concentrations of 1.3 mM. Glycolithocholate inhibited the microTABLE APPARENT
I IKHIBITION
OF
LANOSTEROL
--f
CHOLESTEROL
CONVERSION
BY
BILE
SALTS
1.5 pmoles NAD, 40 m,umoles of [i4C]lanosterol and the indicated amounts of bile salt were incubated either with 4 ml of crude homogenate (IOO-200) mg protein) or with I ml of the suspension of microsomes (20-40 mg protein). Final volumes were 4.3 ml for incubation with crude homogenates and 1.3 ml for microsomes. Incubations were for 15 or 30 min for crude homogenates and microsomes, respectively. All incubations were at 37”. Inhibition is expressed as an average of the percentage of the respective control rate. Values in parentheses represent the number of separate determinations,
Inhibitor*
Deoxycholate Cholate Dehydrocholate Chenodeoxycholate Lithocholate Taurine conjugates Taurodeoxycholate Taurochenodeoxycholate Taurocholate Taurolithocholate Taurodehydrocholate Glycine conjugates Glycodeoxycholate Glycolithocholate Glycochenodeoxycholate Glycocholate Glycodehydrocholate
Homogenate “/6I+zhibition at 1.3 mM 25 (3) + 2.0 19** (2)
1.30
k 6.0
-
13 (2) + 8.5 3 !I) 0 (I) ~1~2.0 52 27 14 4 0
5 (6)
-
(2) (2) (3) (2)
* 17.0 F 17.0 i 2.0 i 2.0
1.30 1.30 -
(2)
_c
I.0
88 (r) 6g (2)
&
11.0
0.20
44 (2) * ‘7 (I) 6 (2) t
3.0
1.30
5:::
1;;
-
I.02
5o*** 5o*** 33 (I)
(4) (4)
-
0.0
* Deoxycholic acid (mp. r74-‘76”; [a]nzS 55 & 0.3’, c = 1.0 in ethanol) was purchased from Sigma Chemical Co. Cholic acid (m.p. log-200.5’; [cz]D’~ 38.4 + 0.3’. c = 0.6 in ethanol) was purchased from Eastman Organic Chemicals. Dehydrocholic acid (m.p. 237-239”; [alDzs 24.8 & 0,3’, c = 1.4 inethanol) andlithocholicacid (m.p. 182-186’; [a]nz3 34 + 0.3’, c = r.5 in ethanol) were purchased from Calbiochem. All other bile acids were purchased as the sodium salt from Calbiochem. The compounds were supplied with accompanying data describing elemental analyses, rotations, homogeneous (thinand melting points, and each compound was labeled “chromatographically layer chromatography)“. ** For ease of comparison, the inhibition observed for 1.3 mM concentrations was calculated from results of experiments conducted with various concentrations: cholate, 2 trials (0.28, 1.4 mM); taurodeoxycholate and taurochenodeoxycholate, 4 trials (0.65, 1.3, 2.6, 5.2 mM). *** The concentration required for 50% inhibition was calculated from results of trials conducted with various concentrations: glycodeoxycholate, 6 trials (o.r-0.9 mM) ; glycolithocholate, 4 trials (0.65, 1.3, 2.6, 5.2 mM).
B&him.
Biophys.
Acta, 137 (1967) 400-402
SHORTCOMMUNICATIONS
402
somal demethylation, and a higher concentration of glycodeoxycholate was inhibitory. In both cases, however, the concentrations required for approx. 50% inhibition were 2 to 5 times the effective concentrations reported by FIMOGNARI AND RODWELL~~~. In addition,
these
most
active
compounds
were glycine
conjugates
of bile acids
(Table I). Bile salts normally formed by rat liver are conjugated to taurine rather than to glycine6. Microsomes were incubated first with either 2.5 mM taurodeoxycholate (weak inhibitor) or 0.3 mM glycolithocholate (strong inhibitor) for o to 30 min. Samples were removed, substrate was added, and the rate of demethylation of lanosterol was measured by a second incubation. Some demethylase activity was lost during the first incubation of microsomes in the absence of bile salts (Fig. I). Treatment of microsomes with glycolithocholate during the first incubation rate of inactivation obtained for the control sample. affect the rate. Microsomes
were incubated
yielded approx. 3 times the Taurodeoxycholate did not
with 0.3 and 0.5 mM glycolithocholate
for 12 min
at 37O. Various amounts of lanosterol were added and the mixtures were incubated for an additional IO min. Graphical analysis of the data suggests that the apparent effect respect
of glycolithocholate
is neither
fully
competitive
nor non-competitive
to the concentration of lanosterol (Fig. 2). The results demonstrate clearly that rather high concentrations
with
of the bile salts
must be added to the incubation medium to obtain significant extents of inhibition of lanosterol demethylation by microsomal enzymes. Further evidence suggests that the inhibition is not specific. Removal of the inert soluble protein from microsomes resulted in the loss of inhibitory activity of some of the compounds (Table I). Bile salts normally biosynthesized in rat liver were inactive. In addition, because the enzymatic
activity
decreased
during prolonged
exposure
of the microsomes
to glyco-
lithocholate, the effect may be ascribed to an enhanced rate of irreversible, timedependent denaturation of the microsomal enzymes. Further, the nature of the inhibition was neither clearly competitive nor non-competitive with respect to lanosterol concentration. The effect of these high concentrations of bile salts may be similar to the less specific interaction of bile salts with lipid-rich microsomal membranes described by HESS AND LAGG'. Thus, the feedback inhibition of bile salts on the hepatic formation of mevalonic acid is the only specific end-product action of bile salts on cholesterol biosynthesis This work was supported of Arthritis
and Metabolic
that has been reported. by Grant AM-04505-06 from the National
Diseases
of the U.S. Public
Health
Graduate School of Nutrition and the Section of Biochenzistvy ami Molecular Biology, Cornell Uni?jersity, Ithaca, N.Y. (U.S.A.) I 2 3 4
LV. L. MILLER J. I,. GAYLOR
Ii.HLoCH, .‘kimce, 150 (1965) 19. (;.M. r;IMOGSARI .\ND v. \v. r
5 J. L. G~YLOR, ,J. Bid. Chem., 239 (1964) 756. 6 G. A. D. HASLEWOOD, Physiol. Rev., 35 (1955) 178. 7 E. L. HESS AND S. E. LAGG, Himhem Biophys. Res. Cowwnzcz,
Received July zznd, 1966 Revised manuscript received Biochinz.
Hioph?s.
Acta,
November
1.37 (1967) 4oo-402
zand, 1966
Institute
Service.
IL (1963) 320.
4 (1965)